ESCA vs IONS · P/E 14, rev $251.5M vs rev $226.6M
Escalade Incorporated (ESCA) versus Ionis Pharmaceuticals Inc (IONS) — a side-by-side from cached financials, not a winner call.
Escalade Incorporated (ESCA) is a leisure company listed on US.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Latest reported ESCA revenue for 2024-12-31 was $251.5M. Net income was $13.0M. Revenue was down 4.6% from 2023-12-31 to 2024-12-31. ESCA currently screens at market cap $192.7M and trailing P/E 14.1.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
ESCA currently screens at market cap $192.7M and trailing P/E 14.1. IONS currently screens at market cap $12.28B.
Not investment advice. Open the ESCA and IONS stock pages for the full models.
Not investment advice.